Perceive Biotherapeutics, Inc. — Form D

Perceive Biotherapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-13. The offering totals $78.0M, of which $40.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-01-13
Form: D
Accession: 0001962036-23-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $78.0M
Amount sold: $40.0M
Remaining: $38.0M
Investors: 6
Date of first sale: 2022-12-29
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-470703

Issuer

Name: Perceive Biotherapeutics, Inc.
CIK: 0001962036
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 6000 SHORELINE DRIVE, SUITE 206, SOUTH SAN FRANCISCO, CA, 94080
Phone: 707-477-8172

Officers, directors & promoters (9)

Name	Role	Location
Watson Angela Debi	Director	South San Francisco, CA
Robert Angela Jackson	Director	South San Francisco, CA
Kirsten Angela Macfarlane	Director	MOUNTAIN VIEW, CA
Randall Angela Olson	Director	South San Francisco, CA
Anne Angela Rubin	Director	South San Francisco, CA
Cameron Angela Wheeler	Director	South San Francisco, CA
Kirsten Angela Macfarlane	Executive Officer	MOUNTAIN VIEW, CA
Anne Angela Rubin	Executive Officer	South San Francisco, CA
Kirsten Angela Macfarlane	Promoter	MOUNTAIN VIEW, CA

More